SERAXIS Trademark

Trademark Overview

On Thursday, May 2, 2013, a trademark application was filed for SERAXIS with the United States Patent and Trademark Office. The USPTO has given the SERAXIS trademark a serial number of 85921494. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 13, 2015. This trademark is owned by Seraxis, Inc. The SERAXIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
seraxis

General Information

Serial Number85921494
Word MarkSERAXIS
Filing DateThursday, May 2, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 13, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2014

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 9, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSeraxis, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGermantown, MD 20876
Party NameSeraxis, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGermantown, MD 20876

Trademark Events

Event DateEvent Description
Monday, April 13, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 13, 2015ABANDONMENT - NO USE STATEMENT FILED
Wednesday, September 10, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 8, 2014EXTENSION 1 GRANTED
Monday, September 8, 2014EXTENSION 1 FILED
Monday, September 8, 2014TEAS EXTENSION RECEIVED
Tuesday, March 11, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 14, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 25, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 11, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 11, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 15, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 15, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 7, 2013ASSIGNED TO LIE
Wednesday, October 30, 2013ASSIGNED TO LIE
Friday, October 25, 2013TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, October 9, 2013NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, October 9, 2013FINAL REFUSAL E-MAILED
Wednesday, October 9, 2013FINAL REFUSAL WRITTEN
Friday, August 30, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 30, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 30, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 21, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 21, 2013NON-FINAL ACTION E-MAILED
Wednesday, August 21, 2013NON-FINAL ACTION WRITTEN
Tuesday, August 20, 2013ASSIGNED TO EXAMINER
Thursday, May 9, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 6, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

seraxis pharmaceuticals clinical trials field information medical scientific research providing